Introduction to retroviruses and retroviral vectors

Somatic Cell and Molecular Genetics

Volumn 26, Issue 1-6, 2001, Pages 1-11

  Buchschacher Jr , Gary L ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RETROVIRUS VECTOR;

GENE TRANSFER; LENTIVIRINAE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; REVIEW; VIRION; VIRUS GENOME; VIRUS REPLICATION;

LENTIVIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0035525965     PISSN: 07407750     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021014728217     Document Type: Review

References (32)

1. Buchschacher GL, Jr., Wong-Staal F. Development of lentiviral vectors for gene therapy for human diseases. Blood 2000; 9:2499-2504.
2. Temin HM, Mizutani S. RNA-dependent DNA polymerase in virions of Rous sarcoma virus. Nature 1970; 226:1211-1213.
3. Poeschla EM, Buchschacher GL, Jr., Wong-Sraal F. Etiology of cancer: RNA viruses. In: DeVita VT, Jr., Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 6th Ed. Philadelphia: Lippincott, Williams & Wilkins, 2000:149-158.
4. Fearon ER. Oncogenes and tumor suppressor genes. In: Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE, eds. Clinical Oncology. 2nd Ed. Philadelphia: Churchill Livingstone, 2000:77-118.
5. Nermut MV, Hockley DJ. Comparitive morphology and structural classification of retroviruses. New Biol 1992; 4:1-24.
6. Coffin JM. Structure and classification of retroviruses. In: Levy JA, ed. The Retroviridae. New York: Plenum Press, 1992:19-50.
7. Coffin JM. Retroviridae: The viruses and their replication. In: Fields BN, Knipe DM, Howley PM et al, eds. Fundamental Virology. 3rd Ed. Philadelphia: Lippincott-Raven Publishers, 1996:763-843.
8. Flint SJ, Enquist LW, Krug RM et al. Reverse transcription and integration: Hallmarks of the retroid viruses. In: Principles of Virology-Molecular Biology, Pathogenesis, and Control. Washington DC: ASM Press, 2000:199-234.
9. Panganiban AT, Fiore D. Ordered interstrand and intrastrand DNA transfer during reverse transcription. Science 1988; 241:1064-1069.
10. Hu Wei-Shau, Temin HM. Retroviral recombination and reverse transcription. Science 1990; 250:1227-1233.
11. Grandgenett DP, Mumm SR. Unraveling retrovirus integration. Cell 1990; 60:3-4.
12. Panganiban AT. Retroviral Reverse Transcription and Integration. 1990; 1:187-194.
13. Skalka AM. Retroviral integration. In: Advances in Virus Research. Maramorosch K, Murphy FA, Shatkin AJ, eds. Seminars in Virology: Retroviral DNA Integration. Vol 52. New York: Academic Press, 1999.
14. Lewis PF, Emerman M. Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J Virol 1994; 68:510-516.
15. Schwartzberg P, Colicelli J, Gordon ML, Goff SP. Mutations in the gag gene of Moloney murine leukemia virus: Effects on production of virions and reverse transcriptase. J Virol 1984; 49:918-924.
16. Felsenstein KM, Goff S. Expression of the gag-pol fusion protein of Moloney murine leukemia virus without gag protein does not induce virion formation or proteolytic processing. J Virol 1988; 62:2179-2182.
17. Jacks T, Power FR, Masiarz PA et al. Characterization of ribosomal frameshifting in HIV-1 gagpol expression. Nature 1988; 331:280-283.
18. Weaver TA, Talbot KJ, Panganiban AT. Spleen necrosis virus gag polyprotein is necessary for particle assembly and release but not for proteolytic processing. J Virol 1990; 64:2642-2652.
19. Butsch M, Boris-Lawrie K. Translation is not required to generate virion precursor RNA in human immunodeficiency virus type 1-infected T cells. J Virol 2000; 74:11531-11537.
20. McBride MS, Panganiban AT. The human immunodeficiency virus type 1 encapsidation site is a multipartite RNA element composed of functional hairpin structures. J Virol 1996; 70:2963-2973.
21. Jewell NA, Mansky LM. In the beginning: Genome recognition, RNA encapsidation and the initiation of complex retrovirus assembly. J Gen Virology 2000; 81:1889-1899.
22. Vogt VM. Proteolytic processing and particle formation. Curr Top Microbiol Immunol 1996; 214:95-132.
23. Kucherova L, Altanerova V, Altaner C, Boris-Lawrie K. Bovine leukemia virus structural gene vectors are immunogenic and lack pathogenicity in a rabbit model. J Virol 1999; 73:8160-8166.
24. Boris-Lawrie KA, Temin HM. Recent advances in retrovirus vector technology. Curr Opin Gen Dev 1993; 3:102-109.
25. Adam MA, Ramesh N, Miller AD et al. Internal initiation of translation in retroviral vectors carrying picornavirus 5′ nontranslated regions. J Virol 1991; 65:4895-4990.
26. Emerman M, Temin HM. Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism. Cell 1984; 39:459-467.
27. Emerman M, Temin HM. Comparison of promoter suppression in avian and murine retrovirus vectors. Nucleic Acids Res 1986; 14:9381-9396.
28. Burns JC, Friedmann T, Driever W et al. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci USA 1993; 90:8033-8037.
29. Hopkins N. High titers of retrovirus (vesicular stomatitis virus) pseudotypes, at last. Proc Natl Acad Sci USA 1993; 90:8759-8760.
30. Miller AD. Retrovirus packaging cells. Human Gene Ther 1990; 1:5-14.
31. Temin HM. Safety considerations in somatic gene therapy of human disease with retrovirus vectors. Hum Gene Ther 1990; 1:111-123.
32. Chong H, Starkey W, Vile RG. A replication-competent retrovirus arising from a split-function packaging cell line was generated by recombination events between the vector, one of the packaging constructs, and endogenous retroviral sequences. J Virol 1998; 72:2663-2670.